Oscar Buisán

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

Vicenç Ruiz de Porras, Xieng C. Wang, Luís Palomero et al. · European Urology · 2020 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer

Oscar Buisán, Anna Orsola, Joan Areal et al. · Clinical Genitourinary Cancer · 2016 · 45 citations

Medicine, Oncology, Urology +13

Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.

Xavier García del Muro, Begoña P. Valderrama, Ana Medina et al. · Journal of Clinical Oncology · 2021 · 34 citations

Medicine, Oncology, Urology +17

Diode laser enucleation of the prostate (Dilep): technique and initial results

Oscar Buisán, J.M. Saladié, Joan Ruíz et al. · Actas Urológicas Españolas (English Edition) · 2011 · 20 citations

Medicine, Surgery, Urology +12

Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy

Oscar Buisán, Anna Orsola, Mario Alves Oliveira et al. · Clinical Genitourinary Cancer · 2017 · 19 citations

Medicine, Oncology, Urology +14